In Vitamin C Price-Fixing Suit, the Second Circuit Vacates Lower Court Ruling as Abuse of Discretion and Defers to China’s Interpretation of Its Laws
In a closely watched case that has been pending in the federal courts for over a decade—a series of private lawsuits alleging that Chinese manufacturers had colluded to fix prices of vitamin C imported into the U.S.—the Second Circuit on Tuesday vacated a $147 million judgment for the plaintiffs and remanded with instructions to dismiss the complaint with prejudice. Defendants had claimed that they had fixed prices at the direction of the Chinese government.
This communication, which we believe may be of interest to our clients and friends of the firm, is for general information only. It is not a full analysis of the matters presented and should not be relied upon as legal advice. This may be considered attorney advertising in some jurisdictions. Please refer to the firm's privacy notice for further details.
Copy link to share post